NDC 70518-3512-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3512
- Requested NDC
- 70518-3512-01
- Package NDCs from labels
- 70518-3512-0, 70518-3512-1, 70518-3512-2, 70518-3512-3, 70518-3512-4, 70518-3512-5, 70518-3512-6, 70518-3512-7, 70518-3512-8, 70518-3512-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3512-0 | Ondansetron | 30 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 30 | 13 | |
| 70518-3512-1 | Ondansetron | 6 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 6 | 13 | |
| 70518-3512-2 | Ondansetron | 10 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 10 | 13 | |
| 70518-3512-3 | Ondansetron | 20 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 20 | 13 | |
| 70518-3512-4 | Ondansetron | 12 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 12 | 13 | |
| 70518-3512-5 | Ondansetron | 9 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 9 | 13 | |
| 70518-3512-6 | Ondansetron | 21 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 21 | 13 | |
| 70518-3512-7 | Ondansetron | 15 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 15 | 13 | |
| 70518-3512-8 | Ondansetron | 3 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 3 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3512 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [REMEDYREPACK INC.] | 7 | Current NDC, Legacy NDC, 9 package rows | 20250313_c0d827d0-333f-4187-ac75-9dc7d34b6169.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70518-3512-0 | EA - Each | 70518-3512 | c09bb726-6922-454a-85e3-77953f31aaa8 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PHOENIX RX LLC | 3a79fc2b-9ea3-a808-e063-6394a90ae794 | 2025-09-22 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PHOENIX RX LLC | 40106070-6a25-5b0e-e063-6394a90a4197 | 2025-09-22 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Vax-Sode | THUJA OCCIDENTALIS, CALCAREA CARBONICA, SILICEA, SALMONELLA TYPHI NOSODE, SERUM ANGUILLAE, BACILLUS TETANI, MALANDRINUM, MORBILLINUM, PAROTIDINUM, RUBELLA NOSODE, YERSINIA ENTEROCOLITICA | Nutritional Specialties, Inc. | cd570e98-c73f-4b38-b5b9-9f16f745ca19 | 2025-09-22 | Warnings | ETJ7Z6XBU4 |
| Ondansetron | ONDANSETRON | Fosun Pharma USA Inc. | e3f22b7e-b6ad-4799-93c7-d30540cada85 | 2025-09-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Libido | HYDRASTIS CANADENSIS, THUJA OCCIDENTALIS, AGNUS CASTUS, ARALIA QUINQUEFOLIA, BARYTA CARBONICA, BERBERIS VULGARIS, BRYONIA, CALADIUM SEGUINUM, CANTHARIS, CAUSTICUM, CHELIDONIUM MAJUS, CINCHONA OFFICINALIS, CONIUM MACULATUM, GAULTHERIA PROCUMBENS, GRAPHITES, KALI CARBONICUM, LYCOPODIUM CLAVATUM, NUX VOMICA, ONOSMODIUM VIRGINIANUM, PHOSPHORUS, SABAL SERRULATA, SELENIUM METALLICUM, SEPIA, SILICEA, STAPHYSAGRIA | Newton Laboratories, Inc. | 9c334fbd-0c1e-eac0-e053-2995a90a9283 | 2025-09-19 | Warnings | ETJ7Z6XBU4 |
| Libido | HYDRASTIS CANADENSIS, THUJA OCCIDENTALIS, AGNUS CASTUS, ARALIA QUINQUEFOLIA, BARYTA CARBONICA, BERBERIS VULGARIS, BRYONIA, CALADIUM SEGUINUM, CANTHARIS, CAUSTICUM, CHELIDONIUM MAJUS, CINCHONA OFFICINALIS, CONIUM MACULATUM, GAULTHERIA PROCUMBENS, GRAPHITES, KALI CARBONICUM, LYCOPODIUM CLAVATUM, NUX VOMICA, ONOSMODIUM VIRGINIANUM, PHOSPHORUS, SABAL SERRULATA, SELENIUM METALLICUM, SEPIA, SILICEA, STAPHYSAGRIA | Newton Laboratories, Inc. | 9c348fa7-1d68-4975-e053-2995a90a0ca6 | 2025-09-19 | Warnings | ETJ7Z6XBU4 |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | 9558d296-8edd-4aa1-875a-6247f9a8374d | 2025-09-15 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0b675b09-fe40-435c-b91a-c61cdf767fbf | 2025-09-15 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | 10afd68b-877f-4819-a314-39f2d56d5db9 | 2025-09-15 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Owell Naturals Draw Salve, Arnica, Silicea | ARNICA MONTANA HPUS, SILICEA HPUS | Owell Naturals Brand LLC | 1c9dab31-de1f-911b-e063-6294a90a0391 | 2025-09-12 | Warnings | ETJ7Z6XBU4 |
| Owell Naturals Draw Salve | ARNICA MONTANA HPUS, SILICEA HPUS | Owell Naturals Brand LLC | 1536ff1e-16b8-fbbc-e063-6394a90a628e | 2025-09-12 | Warnings | ETJ7Z6XBU4 |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | 9083a01b-2fbe-4e04-9eec-bf4f65950ec7 | 2025-09-09 | Warnings | ETJ7Z6XBU4 |
| Schuessler Tissue Salts Comb 12 General Tonic | CALCAREA FLUORICA,CALCAREA PHOSPHORICA,CALCAREA SULPHURICA,FERRUM PHOSPHORICUM ,KALI PHOSPHORICUM,KALI MURIATICUM,KALI SULPHURICUM,MAGNESIA PHOSPHORICA,NATRUM MURIATICUM,NATRUM PHOSPHORICUM,NATRUM SULPHURICUM,SILICEA | Martin & Pleasance Pty Ltd | c14c79ab-85bb-45f2-83d1-1d9c298ffdfd | 2025-09-08 | Warnings | ETJ7Z6XBU4 |
| Ondansetron | ONDANSETRON | Preferred Pharmaceuticals, Inc. | b9abd5ce-6aca-4fda-8f46-0bb5b7fdd5da | 2025-09-04 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 36d64400-2d13-4a1a-a1ca-4741cd3d3f1a | 2025-09-03 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | NorthStar Rx LLC | 9d5e7650-95be-4b96-b29c-374f673eb7a1 | 2025-09-03 | Warnings, Adverse reactions | 312086 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 90e0e508-75f7-4c8b-bb38-898aa4c531c3 | 2025-09-01 | Warnings, Adverse reactions | 312086 198052 NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | ProPharma Distribution | 3d5d25eb-8711-ef8c-e063-6394a90a5e03 | 2025-08-27 | Warnings, Adverse reactions | NMH84OZK2B |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| ONDANSETRON | ONDANSETRON | Apotex Corp. | 2c68d202-fdf7-4b6a-dd7f-82624fcdbd4a | 2025-08-26 | Warnings, Adverse reactions | NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.